Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Osteoporosis
Interventions
DRUG

zoledronic acid

Trial Locations (13)

15213

University of Pittsburgh, Pittsburgh

19610

Radiant Research, Wyomissing

32605

Florida Medical Research Institute, Gainsville

34996

Radiant Research, Stuart

66160

University of Kansas School of Medicine/ Division of Endocrinology, Kansas City

68131

Creighton University Osteoporosis Research Center, Omaha

68516

Arthritis Center of Nebraska, Lincoln

80227

Colorado Center for Bone Research, Lakewood

95403

The Permanente Medical Group, Santa Rosa

97213

Oregon Osteoporosis Center, Portland

98144

Puget Sound Osteoporosis Center, Seattle

01610

Clinical Pharmacology Study Group, Worcester

Unknown

Novartis, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY